Categories

Abbott # 195-264

BINAXNOW COVID-19 ANTIGEN ANTIGEN SELF TEST 12 KITS PER CASE, 2 TESTS PER KIT

SKU Number: MAP00259057
Ships within 24 Hours
Brand: Abbott

450.95 450.95

Log in or create an account to proceed with checkout.



How Can We Help?
Fast answers on bulk discounts, same-day shipping, and other questions for our team
Request Product Info 

Abbott 195-264 - BinaxNOW COVID-19 Antigen Self Test, CLIA Exempt, 12 Kits per Case

The Abbott 195-264 BinaxNOW COVID-19 Antigen Self Test provides a rapid and reliable solution for SARS-CoV-2 antigen detection in professional healthcare settings. This CLIA Exempt test is designed for qualitative detection of the nucleocapsid protein antigen, offering a critical tool for timely infection control and patient management strategies. Procured in bulk, these tests support efficient diagnostic workflows across various institutional environments.

Product Specifications

  • SKU: 195-264
  • Brand: Abbott
  • Model / Reference: BinaxNOW COVID-19 Antigen Self Test
  • Size / Dimensions: 2 Tests per Kit
  • Packaging: 12 Kits per Case
  • Application: COVID-19 Antigen Detection, OTC Self-Testing
  • Certifications / Standards: CLIA Exempt
  • Availability: In Stock

Key Features

  • Rapid Antigen Detection – Qualitatively detects SARS-CoV-2 nucleocapsid protein antigen for quick diagnostic insights.
  • CLIA Exempt Status – Allows for widespread use in diverse professional healthcare settings, simplifying regulatory compliance.
  • User-Friendly Self-Test Format – Each kit contains two tests, facilitating immediate on-site assessment and streamlined workflows.
  • Optimized for Institutional Procurement – Packaged in cases of 12 kits, supporting efficient inventory management and high-volume clinical demand.

Suggested Applications

  • Point-of-care testing in primary care clinics and physician offices.
  • Screening protocols for staff and residents in long-term care facilities.
  • Rapid diagnostic support in occupational health and employee wellness programs.
  • Emergency department and urgent care rapid assessment.

Industries of Use

Hospitals, clinics, long-term care facilities, laboratories, urgent care centers, home health agencies (professional use only), EMS.

The Abbott 195-264 BinaxNOW COVID-19 Antigen Self Test offers healthcare organizations a crucial, compliant, and cost-effective solution for COVID-19 antigen testing. Its CLIA Exempt status and bulk packaging make it an ideal choice for maintaining robust diagnostic capabilities and supporting proactive public health initiatives in professional clinical environments.